Abstract
Teva' s recent acquisition of Barr Pharmaceuticals may be the latest headline
grabbing deal, but industry and commerce alike must have a complete
understanding of the medium-sized generic drug manufacturers. The operating
environment is changing rapidly as the industry matures and growth focuses on
new market opportunities.
View Cart
